ADLM Calls on Feds to Regulate AI in the Clinical Lab Sector
But anti-regulatory stance taken by Trump administration could serve as a potential obstacle in the effort
But anti-regulatory stance taken by Trump administration could serve as a potential obstacle in the effort
What lab leaders should know about the CLIA updates that recently went into effect, and how the changes may impact staffing.
Individualized quality control plans offer flexibility and the capacity to seamlessly adopt new nonwaived tests, practices, and technologies.
With the final rule on PT published July 11, here are the five things lab managers need to know to keep their labs compliant.
CMS has published its list of top 10 most frequently cited Clinical Laboratory Improvement Amendments deficiencies for the previous year.
From - G2 Compliance Advisor
Even as your lab makes the transition to the new, supposedly market-based PAMA Medicare Part B fee schedule for tests, big changes may be in store for another rock of…